These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 35234630)

  • 21. Engineering, structure, and immunogenicity of a Crimean-Congo hemorrhagic fever virus pre-fusion heterotrimeric glycoprotein complex.
    McFadden E; Monticelli SR; Wang A; Ramamohan AR; Batchelor TG; Kuehne AI; Bakken RR; Tse AL; Chandran K; Herbert AS; McLellan JS
    bioRxiv; 2024 Apr; ():. PubMed ID: 38659837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse models.
    Garrison AR; Shoemaker CJ; Golden JW; Fitzpatrick CJ; Suschak JJ; Richards MJ; Badger CV; Six CM; Martin JD; Hannaman D; Zivcec M; Bergeron E; Koehler JW; Schmaljohn CS
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005908. PubMed ID: 28922426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mapping of Antibody Epitopes on the Crimean-Congo Hemorrhagic Fever Virus Nucleoprotein.
    Lombe BP; Saito T; Miyamoto H; Mori-Kajihara A; Kajihara M; Saijo M; Masumu J; Hattori T; Igarashi M; Takada A
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35336951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crimean-Congo Hemorrhagic Fever Virus, Mongolia, 2013-2014.
    Voorhees MA; Padilla SL; Jamsransuren D; Koehler JW; Delp KL; Adiyadorj D; Baasandagwa U; Jigjav B; Olschner SP; Minogue TD; Schoepp RJ
    Emerg Infect Dis; 2018 Dec; 24(12):2202-2209. PubMed ID: 30457521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Convalescent human plasma candidate reference materials protect against Crimean-Congo haemorrhagic fever virus (CCHFV) challenge in an A129 mouse model.
    Kempster S; Hassall M; Graham V; Kennedy E; Findlay-Wilson S; Salguero FJ; Bagci B; Elaldi N; Oz M; Tasseten T; Charlton FW; Barr JN; Fontana J; Duru C; Ezeajughi E; Matejtschuk P; Arnold U; Adedeji Y; Mirazimi A; Hewson R; Dowall S; Almond N
    Virus Res; 2024 Aug; 346():199409. PubMed ID: 38815869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactome profiling of Crimean-Congo hemorrhagic fever virus glycoproteins.
    Dai S; Min YQ; Li Q; Feng K; Jiang Z; Wang Z; Zhang C; Ren F; Fang Y; Zhang J; Zhu Q; Wang M; Wang H; Deng F; Ning YJ
    Nat Commun; 2023 Nov; 14(1):7365. PubMed ID: 37963884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heat Shock Protein 70 Family Members Interact with Crimean-Congo Hemorrhagic Fever Virus and Hazara Virus Nucleocapsid Proteins and Perform a Functional Role in the Nairovirus Replication Cycle.
    Surtees R; Dowall SD; Shaw A; Armstrong S; Hewson R; Carroll MW; Mankouri J; Edwards TA; Hiscox JA; Barr JN
    J Virol; 2016 Oct; 90(20):9305-16. PubMed ID: 27512070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of codon usage bias of Crimean-Congo hemorrhagic fever virus and its adaptation to hosts.
    Rahman SU; Yao X; Li X; Chen D; Tao S
    Infect Genet Evol; 2018 Mar; 58():1-16. PubMed ID: 29198972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seroprevalence of Crimean-Congo Hemorrhagic Fever Virus in Erzincan Province, Turkey, Relationship with Geographic Features and Risk Factors.
    Cikman A; Aydin M; Gulhan B; Karakecili F; Kesik OA; Ozcicek A; Akin H; Kara M
    Vector Borne Zoonotic Dis; 2016 Mar; 16(3):199-204. PubMed ID: 26808904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural characterization of protective non-neutralizing antibodies targeting Crimean-Congo hemorrhagic fever virus.
    Durie IA; Tehrani ZR; Karaaslan E; Sorvillo TE; McGuire J; Golden JW; Welch SR; Kainulainen MH; Harmon JR; Mousa JJ; Gonzalez D; Enos S; Koksal I; Yilmaz G; Karakoc HN; Hamidi S; Albay C; Spengler JR; Spiropoulou CF; Garrison AR; Sajadi MM; Bergeron É; Pegan SD
    Nat Commun; 2022 Nov; 13(1):7298. PubMed ID: 36435827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vesicular Stomatitis Virus-Based Vaccine Protects Mice against Crimean-Congo Hemorrhagic Fever.
    Rodriguez SE; Cross RW; Fenton KA; Bente DA; Mire CE; Geisbert TW
    Sci Rep; 2019 May; 9(1):7755. PubMed ID: 31123310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The complete genome analysis of Crimean-Congo hemorrhagic fever virus isolated in Turkey.
    Ozdarendeli A; Canakoğlu N; Berber E; Aydin K; Tonbak S; Ertek M; Buzgan T; Bolat Y; Aktaş M; Kalkan A
    Virus Res; 2010 Feb; 147(2):288-93. PubMed ID: 19941917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent advances in understanding Crimean-Congo hemorrhagic fever virus.
    Hawman DW; Feldmann H
    F1000Res; 2018; 7():. PubMed ID: 30416710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crimean-Congo Hemorrhagic Fever Mouse Model Recapitulating Human Convalescence.
    Hawman DW; Meade-White K; Haddock E; Habib R; Scott D; Thomas T; Rosenke R; Feldmann H
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31292241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seroepidemiological Investigation of Crimean-Congo Hemorrhagic Fever Virus in Sheep and Camels of Inner Mongolia of China.
    Li Y; Yan C; Liu D; He B; Tu C
    Vector Borne Zoonotic Dis; 2020 Jun; 20(6):461-467. PubMed ID: 32155395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fine epitope mapping of the central immunodominant region of nucleoprotein from Crimean-Congo hemorrhagic fever virus (CCHFV).
    Liu D; Li Y; Zhao J; Deng F; Duan X; Kou C; Wu T; Li Y; Wang Y; Ma J; Yang J; Hu Z; Zhang F; Zhang Y; Sun S
    PLoS One; 2014; 9(11):e108419. PubMed ID: 25365026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crimean-Congo hemorrhagic fever virus replication imposes hyper-lipidation of MAP1LC3 in epithelial cells.
    Moroso M; Verlhac P; Ferraris O; Rozières A; Carbonnelle C; Mély S; Endtz HP; Peyrefitte CN; Paranhos-Baccalà G; Viret C; Faure M
    Autophagy; 2020 Oct; 16(10):1858-1870. PubMed ID: 31905032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunocompetent mouse model for Crimean-Congo hemorrhagic fever virus.
    Hawman DW; Meade-White K; Leventhal S; Feldmann F; Okumura A; Smith B; Scott D; Feldmann H
    Elife; 2021 Jan; 10():. PubMed ID: 33416494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serological and molecular study of Crimean-Congo Hemorrhagic Fever Virus in cattle from selected districts in Uganda.
    Balinandi S; von Brömssen C; Tumusiime A; Kyondo J; Kwon H; Monteil VM; Mirazimi A; Lutwama J; Mugisha L; Malmberg M
    J Virol Methods; 2021 Apr; 290():114075. PubMed ID: 33515661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crimean-Congo hemorrhagic fever virus in livestock ticks and animal handler seroprevalence at an abattoir in Ghana.
    Akuffo R; Brandful JA; Zayed A; Adjei A; Watany N; Fahmy NT; Hughes R; Doman B; Voegborlo SV; Aziati D; Pratt D; Awuni JA; Adams N; Dueger E
    BMC Infect Dis; 2016 Jul; 16():324. PubMed ID: 27392037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.